3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
93
NIH
31
NETWORK
13
INDUSTRY
13
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
11
Neoplasm Metastasis
6
Stomach Neoplasms
5
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
2
Sarcoma
1
Recurrence
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Colonic Neoplasms
1
Breast Neoplasms
1
Breast Cancer Metastatic
1
Interventions
Capecitabine
8
Fluorouracil
6
Radiotherapy
5
Leucovorin
5
Oxaliplatin
4
Laparoscopy
4
XELOX
3
Cetuximab
3
Irinotecan
2
Folfox protocol
2
Drug Therapy
2
Chemoradiotherapy
2
selinexor
1
citric acid, ispaghula husk, sodium bicarbonate drug combination
1
capecitabine-irinotecan combination
1
Vitamin D Response Element
1
Vi-siblin
1
Transanal Endoscopic Microsurgery
1
Robotics
1
Robotic Surgical Procedures
1
Psyllium
1
Polyethylene Glycols
1
N-hydroxy-4-acetylaminostilbene
1
Metronidazole
1
Mastectomy, Segmental
1
Liver Extracts
1
Immunohistochemistry
1
Frozen Sections
1
Fluorescein Angiography
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Rectal Neoplasms
×
Irinotecan
×
Clear all
NCT00557102
2012-12-11
ERBIFORT
National Cancer Institute, France
Phase 2
Completed
24 enrolled
NCT00506844
2007-07-25
ERBIRIX
National Cancer Center, Korea
Phase 2
Unknown
40 enrolled